Cited by 126Alzheimer's disease research and treatmentsMedicinal Plants and NeuroprotectionCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 291 of the 294 references it cites were found in a registry or an index.

The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease

Divino da Rocha, Miguel, Pereira Dias Viegas, Flavia, Cristina Campos, Helineide, Carolina Nicastro, Patricia, Calve Fossaluzza, Poliana, Alberto Manssour Fraga, Carlos, J. Barreiro, Eliezer, Viegas, Claudio·2011·CNS & Neurological Disorders - Drug Targets

DOI 10.2174/187152711794480429

Open this paper in CoChat — free account

Abstract

The present review is part II in a series (part I focuses on Parkinson's Disease) that addresses the value of natural product chemistry in the discovery of medicines for the treatment of neurodegenerative disorders. Data reviewed document that a host of products from plant species and derivatives have neuroprotectant effects in vitro and in vivo. In addition, besides neuroprotection, natural products also demonstrate biological effects that target biochemical pathways underlying associated symptoms of neurdegnerative disorders that include cognitive impairments, energy/fatigue, mood, and anxiety. This part of the review series focuses specifically upon Alzheimer's Disease (AD). AD is postulated to result from extracellular formation of amyloid plaques and intracellular deposits of neurofibrilary tangles in the hippocampus, cerebral cortex and other areas of the brain essential for cognitive function. Plaques are formed mostly from the deposition β-amyloid (Aβ), a peptide derived from the amyloid precursor protein (APP). Filamentous tangles are formed from paired helical filaments composed of neurofilament and hyperphosphorilated tau protein, a microtubule-associated protein. In addition, environmental factors can engender the production of cytokines that are closely related to the installation of an inflammatory process that contributes to neuronal death and the development and the progression of AD. In this review we focus on the recent main contribuitions of natural products chemistry to the discovery of new chemical entities usefull to the control and prevention of AD installation and progression. More than sixteen plant species, including Ginseng, Celastrus paniculatus, Centella asiatica, Curcuma longa, Ginkgo biloba, Huperzia serrata, Lycoris radiate, Galanthus nivalis, Magnolia officinalis, Polygala tenuifolia, Salvia lavandulaefolia, Salvia miltiorrhiza, Coptis chinensis, Crocus sativus, Evodia rutaecarpa, Sanguisorba officinalis, Veratrum grandiflorum and Picrorhiza kurvoa, are discussed as potential sources of active extracts. In addition, more than sixty secondary metabolites are under evaluation for their efficacy on controlling symptoms and to impede the development and progression of AD.

Integrity signals

Registry

Crossref · 10.2174/187152711794480429

Cites

291 of 291 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype*
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84
Retracted
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Parkinson's Disease
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479
Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate
Olney, J. (1969) · Science · doi:10.1126/science.164.3880.719 · Cited by 1,885
Medicinal natural products: A biosynthetic approach
(2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01302-2 · Cited by 1,698
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
Natural Products in Drug Discovery and Development
Cragg, G. M. L., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,605
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits
Kaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285
Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?
Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,262
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
Small, G. W. (1997) · JAMA · doi:10.1001/jama.1997.03550160083043 · Cited by 992
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Central Nervous System
Peters, A., & Vaughan, D. W. (1981) · Springer eBooks · doi:10.1007/978-1-4684-3929-8_1 · Cited by 900
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 835
Review on some plants of Indian traditional medicine with antioxidant activity
Scartezzini, P., & Speroni, E. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00213-0 · Cited by 818
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodríguez-Oroz, M. C., Goetz, C. G., Marin, C. A., Kordower, J. H., Rodrı́guez, M., Hirsch, É. C., Farrer, M. J., Schapira, A. H. V., & Halliday, G. M. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 776
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 766
ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 717
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 687
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 683
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Dexter, D. T., Daniel, S. E., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 660
Characteristics of the Inhibition of NADPH Oxidase Activation in Neutrophils by Apocynin, a Methoxy-Substituted Catechol
Stolk, J. N., Hiltermann, T. J. N., Dijkman, J. H., & Verhoeven, A. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.1.8018341 · Cited by 650
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 623
Environmental risk factors and Parkinson's disease
Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Antioxidant activities of polyphenols from sage (Salvia officinalis)
Lu, Y., & Foo, L. Y. (2001) · Food Chemistry · doi:10.1016/s0308-8146(01)00198-4 · Cited by 594
β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585
Resveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, Á., Lubahn, D. E., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 528
Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica
Brinkhaus, B., Lindner, M., Schuppan, D., & Hahn, E. G. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80065-3 · Cited by 525
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 523
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
Shu, Y. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 518
The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease
Thiruchelvam, M. J., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory‐Slechta, D. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
A Hundred Years of Alzheimer's Disease Research
Hardy, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.016 · Cited by 467
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
Selkoe, D. J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3111 · Cited by 466
In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes
Perry, N. S. L., Houghton, P. J., Theobald, A. E., Jenner, P. G., & Perry, E. K. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774598 · Cited by 458
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases
Mandel, S. A., & Youdim, M. B. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.012 · Cited by 453
Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function
Howes, M. R., & Houghton, P. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00128-x · Cited by 443
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H., Hong, J., Zhang, W., & Liu, B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory‐Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 425
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders
Howes, M. R., Perry, N. S. L., & Houghton, P. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1280 · Cited by 421
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 398
Mutational analysis of the glycine-binding site of the NMDA receptor: Structural similarity with bacterial amino acid-binding proteins
Kuryatov, A. (1994) · Neuron · doi:10.1016/0896-6273(94)90445-6 · Cited by 385
Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases
Mandel, S. A., Weinreb, O., Amit, T., & Youdim, M. B. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02291.x · Cited by 384
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial
Perry, N. S. L., Bollen, C. S. C., Perry, E. K., & Ballard, C. G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00108-4 · Cited by 384
The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid
Bastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 383
Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct Dementia
Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369
Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil
Savelev, S. U., Okello, E. J., Perry, N. S. L., Wilkins, R. M., & Perry, E. K. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00125-4 · Cited by 366
The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid Release
Murakami, M., Shimbara, S., Kambe, T., Kuwata, H., Winstead, M. V., Tischfield, J. A., & Kudo, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14411 · Cited by 366
NADPH Oxidases of the Brain: Distribution, Regulation, and Function
Infanger, D. W., Sharma, R. V., & Davisson, R. L. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1583 · Cited by 365
Plant-insect coevolution and inhibition of acetylcholinesterase
Ryan, M. F., & Byrne, O. (1988) · Journal of Chemical Ecology · doi:10.1007/bf01013489 · Cited by 357
Plants and the central nervous system
Carlini, E. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00112-6 · Cited by 357
Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats
Sinha, K., Chaudhary, G., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 356
Multifunctional Activities of Green Tea Catechins in Neuroprotection
Mandel, S. A., Avramovich‐Tirosh, Y., Reznichenko, L., Zheng, H., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · Neurosignals · doi:10.1159/000085385 · Cited by 347
Inflammaging as a prodrome to Alzheimer's disease
Giunta, B., Fernandez, F., Nikolic, W. V., Obregon, D., Rrapo, E., Town, T., & Tan, J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-51 · Cited by 327
Expression of Concern: Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 325
Neurotoxicant-induced animal models of Parkinson?s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 317
Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 315
The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review
Miquel, J., Bernd, A., Sempere, J. M., Dı́az-Alperi, J., & Ramı́rez, A. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00194-7 · Cited by 309
Metabolism of 20(S)- and 20(R)-Ginsenoside Rg3 by Human Intestinal Bacteria and Its Relation to in Vitro Biological Activities.
Bae, E., Han, M. J., Choo, M., Park, S., & Kim, D. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.58 · Cited by 307
Oxidative and Inflammatory Pathways in Parkinson’s Disease
Miller, R. L., James-Kracke, M., Sun, G. Y., & Sun, A. Y. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9656-2 · Cited by 306
Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease
Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0109fje · Cited by 306
The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers
Wesnes, K. A., Ward, T., McGinty, A., & Petrini, O. (2000) · Psychopharmacology · doi:10.1007/s002130000533 · Cited by 305
Cytotoxicity, antioxidant and anti-inflammatory activities of Curcumins I–III from Curcuma longa
Ramsewak, R. S., DeWitt, D. L., & Nair, M. G. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80048-3 · Cited by 302
Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C
Han, Y.-S., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 300
Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease
Wang, J., Ho, L., Zhao, Z., Seror, I., Humala, N., Dickstein, D. L., Thiyagarajan, M., Percival, S. S., Talcott, S. T., & Pasinetti, G. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6281com · Cited by 299
Antidepressant activity of aqueous extracts of Curcuma longa in mice
Yu, Z. F., Kong, L., & Chen, Y. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00211-8 · Cited by 296
Antioxidant Action of Ginkgo Biloba Extract (EGB 761)
Packer, L. (1997) · Springer eBooks · doi:10.1007/978-1-4899-1837-6_7 · Cited by 291
Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A 2 in cortical neurons
Shelat, P. B., Chalimoniuk, M., Wang, J., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05347.x · Cited by 288
Signal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288
A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals
Tischfield, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17247 · Cited by 284
Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult: A Drug Discovery Effort against Alzheimer's Disease
Park, S., & Kim, D. S. H. L. (2002) · Journal of Natural Products · doi:10.1021/np010039x · Cited by 278
Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Parkinson's disease
Semchuk, K. M., Love, E. J., & Lee, R. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1173 · Cited by 275
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J., Dong, Y. X., Wang, J., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274
Oxidative and Antioxidative Potential of Brain Microglial Cells
Dringen, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1223 · Cited by 270
Use of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Radad, K., Gille, G., Liu, L., & Rausch, W. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05010x · Cited by 268
Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1–42) insult
Kim, D. S. H. L., Park, S., & Kim, J.-Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01677-9 · Cited by 262
Sources and Targets of Reactive Oxygen Species in Synaptic Plasticity and Memory
Kishida, K. T., & Klann, E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-8 · Cited by 258
Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism
Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2000) · Psychopharmacology · doi:10.1007/s002130000501 · Cited by 255
Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease
Gao, H., Hong, J., Zhang, W., & Liu, B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores, G. M., Huger, F. P., Petko, W. W., Mutlib, A. E., Camacho, F., Rush, D. K., Selk, D. E., Wolf, V., Kosley, R. W., Davis, L., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12928-5 · Cited by 249
Ginseng: potential for the enhancement of cognitive performance and mood
Kennedy, D. O., & Scholey, A. B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00126-6 · Cited by 245
Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes
Liu, G.-T., Zhang, T., Wang, B.-E., & Wang, Y. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90271-j · Cited by 244
Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice
Inoue, H., Jiang, X., Katayama, T., Osada, S., Umesono, K., & Namura, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.001 · Cited by 238
Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)
Pietri, S., Maurelli, E., Drieu, K., & Culcasi, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0316 · Cited by 236
Nuclear import of PKCδ is required for apoptosis: identification of a novel nuclear import sequence
DeVries, T. A., Neville, M. C., & Reyland, M. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf606 · Cited by 236
Chemical Constituents of Polygonaceous Plants. I
Nonomura, S., Kanagawa, H., & Makimoto, A. (1963) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.83.10_988 · Cited by 233
Pesticides and Risk of Parkinson Disease
Firestone, J. A., Smith‐Weller, T., Franklin, G. M., Swanson, P. D., Longstreth, W. T., Jr., & Checkoway, H. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.91 · Cited by 232
Botanical Phenolics and Brain Health
Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8052-z · Cited by 229
The Ginkgo biloba Extract (EGb 761) Protects and Rescues Hippocampal Cells Against Nitric Oxide‐Induced Toxicity
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742268.x · Cited by 222
The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region.
Hirai, H., Kirsch, J., Laube, B., Betz, H., & Kuhse, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6031 · Cited by 221
Determination of Stilbenes (trans-Astringin,cis- andtrans-Piceid, andcis- andtrans-Resveratrol) in Portuguese Wines
Lima, T., Waffo‐Téguo, P., Teissèdre, P., Pujolas, A., Vercauteren, J., Cabanis, J. C., & Mérillon, J. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9900884 · Cited by 220
Neuroprotection by resveratrol against traumatic brain injury in rats
Ateş, Ö., Cayli, S. R., Altınöz, E., Gürses, İ., Yücel, N., Sener, M., Koçak, A., & Yoloğlu, S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9253-0 · Cited by 219
Caspase-3-Dependent Proteolytic Cleavage of Protein Kinase Cδ Is Essential for Oxidative Stress-Mediated Dopaminergic Cell Death after Exposure to Methylcyclopentadienyl Manganese Tricarbonyl
Anantharam, V., Kitazawa, M., Wagner, J. R., Kaul, S., & Kanthasamy, A. G. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01738.2002 · Cited by 219
Mechanisms of MAPK signalling specificity
Bardwell, L. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340837 · Cited by 217
A mechanism of paraquat toxicity involving nitric oxide synthase
Day, B. J., Patel, M., Calavetta, L., Chang, L.-Y., & Stamler, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12760 · Cited by 213
Curcumin (diferuloylmethane), a singlet oxygen (1O2) quencher
Das, K. C., & Das, C. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00633-2 · Cited by 208
Inhibition of Acetylcholinesterase Activity by Monoterpenoids with a p-Menthane Skeleton
Miyazawa, M., Watanabe, H., & Kameoka, H. (1997) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf960398b · Cited by 208
Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
Chanvitayapongs, S., Draczynska‐Lusiak, B., & Sun, A. Y. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00035 · Cited by 206
Microglia Proliferation Is Regulated by Hydrogen Peroxide from NADPH Oxidase
Mander, P. K., Jekabsone, A., & Brown, G. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1046 · Cited by 206
Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets
Srivastava, K. C., Bordia, A., & Verma, S. K. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90040-3 · Cited by 204
Determination of biologically active constituents in Centella asiatica
Inamdar, P. K., Yeole, R. D., Ghogare, A. B., & SOUZA, N. J. D. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(96)00237-3 · Cited by 197
Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury.
Zhao, B., Jiang, W., Zhao, Y., Hou, J. W., & Xin, W. J. (1996) · PubMed · Cited by 193
Anti-anxiety studies on extracts of Passiflora incarnata Linneaus
Dhawan, K., Kumar, S., & Sharma, A. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00339-7 · Cited by 192
Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases
Rocha-González, H. I., Ambriz‐Tututi, M., & Granados‐Soto, V. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00045.x · Cited by 190
Appearance of Compound K, a Major Metabolite of Ginsenoside Rb1 by Intestinal Bacteria, in Rat Plasma after Oral Administration. Measurement of Compound K by Enzyme Immunoassay.
Akao, T., Kanaoka, M., & Kobashi, K. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.245 · Cited by 189
Determination of the Phytoalexin Resveratrol (3,5,4‘-Trihydroxystilbene) in Peanuts and Pistachios by High-Performance Liquid Chromatographic Diode Array (HPLC-DAD) and Gas Chromatography−Mass Spectrometry (GC-MS)
Tokuşoğlu, Ö., Ünal, M. K., & Yemiş, F. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050496+ · Cited by 183
A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimers Type
Schneider, L. S., DeKosky, S. T., Farlow, M. R., Tariot, P. N., Hoerr, R., & Kieser, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932287 · Cited by 182
The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands
Yao, Z., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181
In vitro andin vivo activity of eugenol on human herpesvirus
Benencia, F., & Courr�ges, M. C. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200011)14:7 · Cited by 181
Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists
Butterfield, D. A., Griffin, S. T., Münch, G. W., & Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4309 · Cited by 176
Free Radical Reactions of Curcumin in Membrane Models
Priyadarsini, K. I. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00026-9 · Cited by 174
Os produtos naturais e a química medicinal moderna
Viegas, C., Bolzani, V. D. S., & Barreiro, E. J. (2006) · Química Nova · doi:10.1590/s0100-40422006000200025 · Cited by 173
Self-citation
Protein Kinase Cδ Is Required for p47phox Phosphorylation and Translocation in Activated Human Monocytes
Bey, E. A., Xu, B., Bhattacharjee, A., Oldfield, C. M., Zhao, X., Li, Q., Subbulakshmi, V., Feldman, G. M., Wientjes, F. B., & Cathcart, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5730 · Cited by 172
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice
Rajeswari, A., & Sabesan, M. (2008) · Inflammopharmacology · doi:10.1007/s10787-007-1614-0 · Cited by 170
The pharmacology of galanthamine and its analogues
Harvey, A. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02002-0 · Cited by 169
Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms
Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00014 · Cited by 167
Evaluation In Vitro of Plant Essential Oils as Natural Antioxidants
Dorman, H. J. D., Deans, S. G., Noble, R. C., & Surai, P. F. (1995) · Journal of Essential Oil Research · doi:10.1080/10412905.1995.9700520 · Cited by 166
Membrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens
Farooqui, A. A., Rapoport, S. I., & Horrocks, L. A. (1997) · Neurochemical Research · doi:10.1023/a:1027380331807 · Cited by 165
Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse
Soulimani, R., Younos, C., Jarmouni, I. S., Bousta, D., Misslin, R., & Mortier, F. (1997) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00042-1 · Cited by 165
A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761® in Dementia
Bars, P. L. L., Kieser, M., & Itil, K. Z. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017242 · Cited by 164
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis‐Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P. G., Milligan, S. R., et al. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777846 · Cited by 161
Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms
Barbieri, S. S., Cavalca, V., Eligini, S., Brambilla, M., Caiani, A., Tremoli, E., & Colli, S. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.020 · Cited by 161
Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra
Peng, J., Stevenson, F. F., Doctrow, S. R., & Andersen, J. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500984200 · Cited by 159
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., de Yébenes, J. G., & Mena, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03777.x · Cited by 156
Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
Rezai-Zadeh, K. P., Shytle, R. D., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D. F., Town, T., & Tan, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 155
Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00665-0 · Cited by 150
Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice
Connelly, L., Madhani, M., & Hobbs, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411991200 · Cited by 149
Studies on Absorption, Distribution, Excretion and Metabolism of Ginseng Saponins. VII. Comparison of the Decomposition Modes of Ginsenoside-Rb1 and -Rb2 in the Digestive Tract of Rats.
Karikura, M., Miyase, T., Tanizawa, H., TANIYAMA, T., & Takino, Y. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.2357 · Cited by 148
Gingko Biloba: A Case Report of Herbal Medicine and Bleeding Postoperatively from a Laparoscopic Cholecystectomy
Fessenden, J., Wittenborn, W., & Clarke, L. E. (2001) · The American Surgeon · doi:10.1177/000313480106700108 · Cited by 147
Neuroprotective Effects of Resveratrol against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress in Rats
Kumar, A., Naidu, P. S., Seghal, N., & Padi, S. S. V. (2006) · Pharmacology · doi:10.1159/000097511 · Cited by 147
Mechanism of inhibition of cholinesterases by huperzine A
Ashani, Y., Peggins, J. O., & Doctor, B. P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90649-6 · Cited by 144
A double-blind, placebo controlled study of Ginkgo biloba extract (‘Tanakan’) in elderly outpatients with mild to moderate memory impairment
S, G., Shovlin, C. L., & Wesnes, K. A. (1991) · Current Medical Research and Opinion · doi:10.1185/03007999109111504 · Cited by 144
Novel Anticholinesterase and Antiamnesic Activities of Dehydroevodiamine, a Constituent ofEvodia rutaecarpa
Park, C., Kim, S., Choi, W., Lee, Y. J., Kim, J., Kang, S. S., & Sun, Y. (1996) · Planta Medica · doi:10.1055/s-2006-957926 · Cited by 143
Quality of life and parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39)
Bushnell, D. M., & Martin, M. L. (1999) · Quality of Life Research · doi:10.1023/a:1008979705027 · Cited by 142
Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity
Mook‐Jung, I., Shin, J., Yun, S. H., Huh, K., Koh, J. Y., Park, H. K., Jew, S., & Jung, M. W. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991101)58:3 · Cited by 140
HPLC Separation and Quantitative Determination of Ginsenosides from Panax ginseng, Panax quinquefolium and from Ginseng Drug Preparations
Soldati, F., & Sticher, O. (1980) · Planta Medica · doi:10.1055/s-2008-1074929 · Cited by 140
Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats
Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O., & Shiono, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02750-1 · Cited by 139
Dose Dependent Changes in Cognitive Performance and Mood following Acute Administration ofGinsengto Healthy Young Volunteers
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2001) · Nutritional Neuroscience · doi:10.1080/1028415x.2001.11747370 · Cited by 138
NADPH oxidase is required for NMDA receptor‐dependent activation of ERK in hippocampal area CA1
Kishida, K. T., Pao, M., Holland, S. M., & Klann, E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03189.x · Cited by 136
The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigation
Hofferberth, B. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090308 · Cited by 134
Antioxidant property of Celastrus paniculatus Willd.: A possible mechanism in enhancing cognition
Kumar, M. H. V., & Gupta, Y. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00136 · Cited by 133
Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT‐11
Park, C. H., Choi, S. H., Koo, J., Seo, J., Kim, H., Jeong, S., & Suh, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10429 · Cited by 131
Antioxidant Activity of Leaves of Salvia Species in Enzyme-Dependent and Enzyme-Independent Systems of Lipid Peroxidation and their Phenolic Constituents
Zupkó, I., Hohmann, J., Rédei, D., Falkay, G., Janicsák, G., & Máthé, I. (2001) · Planta Medica · doi:10.1055/s-2001-14327 · Cited by 129
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia–reperfusion in mice
Gao, D., Zhang, X., Jiang, X., Peng, Y., Huang, W., Cheng, G. S., & Song, L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.030 · Cited by 129
Ginkgo Biloba Extract (EGb 761) Independently Improves Changes in Passive Avoidance Learning and Brain Membrane Fluidity in the Aging Mouse
Stoll, S., Scheuer, K., Pohl, O., & Müller, W. E. G. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-979561 · Cited by 128
Manganese-Induced Dopaminergic Neurodegeneration: Insights into Mechanisms and Genetics Shared with Parkinson’s Disease
Benedetto, A., Au, C., & Aschner, M. (2009) · Chemical Reviews · doi:10.1021/cr800536y · Cited by 127
Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba
GALLUZZI, S. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.679a · Cited by 125
Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin
Conte, A., Pellegrini, S., & Tagliazucchi, D. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.08.001 · Cited by 124
Cohort analysis of Parkinson's syndrome
Poskanzer, D. C., & Schwab, R. S. (1963) · Journal of Chronic Diseases · doi:10.1016/0021-9681(63)90098-5 · Cited by 122
Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischemia
Wen, T., Yoshimura, H., Matsuda, S., Lim, J.-H., & Sakanaka, M. (1995) · Acta Neuropathologica · doi:10.1007/s004010050387 · Cited by 122
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0242-8 · Cited by 119
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire‐Zeiss, K. A., Short, D. W., & Federoff, H. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.014 · Cited by 115
Protein kinase C isoforms as therapeutic targets in nervous system disease states
Battaini, F. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0893 · Cited by 115
Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate
Ved, H. S., Koenig, M. L., Dave, J. R., & Doctor, B. P. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00029 · Cited by 115
Unique Properties of Polyphenol Stilbenes in the Brain: More than Direct Antioxidant Actions; Gene/Protein Regulatory Activity
Doré, S. (2005) · Neurosignals · doi:10.1159/000085386 · Cited by 113
Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia
Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Drieu, K., & Fiskum, G. M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03188-2 · Cited by 112
The Bipyridyl Herbicide Paraquat Produces Oxidative Stress-Mediated Toxicity in Human Neuroblastoma SH-SY5Y Cells: Relevance to the Dopaminergic Pathogenesis
Yang, W., & Tiffany‐Castiglioni, E. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500226987 · Cited by 112
Improvement in organically disturbed behavior with trazodone treatment.
Simpson, D. M., & Foster, D. (1986) · PubMed · Cited by 108
Age-related increase of oxidative stress-induced apoptosis in micePrevention by Ginkgo biloba extract (EGb761)
Schindowski, K., Leutner, S., Kressmann, S., Eckert, A., & Müller, W. E. G. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170016 · Cited by 106
Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats
Chopin, P., & Briley, M. (1992) · Psychopharmacology · doi:10.1007/bf02253584 · Cited by 105
Anti-inflammatory and analgesic effects of magnolol
Wang, J.-P., Hsu, M., Raung, S.-Z., Chen, C., Kuo, J., & Teng, C. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168746 · Cited by 103
Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells
Miloso, M., Bertelli, A. A. E., Nicolini, G., & Tredici, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00194-9 · Cited by 101
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3
Uhlik, M. T., Abell, A. N., Cuevas, B. D., Nakamura, K., & Johnson, G. L. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-114 · Cited by 101
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 101
Differential, Dose Dependent Changes in Cognitive Performance Following Acute Administration of aGinkgo biloba/Panax ginsengCombination to Healthy Young Volunteers
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2001) · Nutritional Neuroscience · doi:10.1080/1028415x.2001.11747376 · Cited by 100
Evaluation of Commercial Ginseng Products
Liberti, L. E., & Marderosian, A. D. (1978) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600671050 · Cited by 100
Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine
Lee, M. K., Kang, S. J., Poncz, M., Song, K., & Park, K. S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.42 · Cited by 99
Neuropathology of Parkinson’s Disease and Related Syndromes
Gibb, W. R. G. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30215-9 · Cited by 99
Cognitive Improving and Cerebral Protective Effects of Acylated Oligosaccharides in Polygala tenuifolia
Ikeya, Y., Takeda, S., Tunakawa, M., Karakida, H., Toda, K., Yamaguchi, T., & Aburada, M. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1081 · Cited by 98
Mitogen-activated protein kinase (MAPK)
Cuschieri, J., & Maier, R. V. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000191714.39495.a6 · Cited by 96
Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons
Alvira, D., Yeste‐Velasco, M., Folch, J., Verdaguer, E., Canudas, A. M., Pallàs, M., & Camins, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.029 · Cited by 96
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
Bickel, U., Thomsen, T., Weber, W., Fischer, J. P., Bachus, R., Nitz, M., & Kewitz, H. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.159 · Cited by 94
Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury
Xiao, X., Yang, J., & Tang, X. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00695-3 · Cited by 90
Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells
Kim, Y., Lim, S., Rhee, S., Park, K., Kim, C., Choi, B., Lee, S. J., Park, Y., & Choi, Y. H. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1069 · Cited by 90
Enhanced maze performance and reduced oxidative stress by combined extracts of zingiber officinale and ginkgo biloba in the aged rat
Topic, B., Tani, E., Tsiakitzis, K. C., Kourounakis, P. N., Dere, E., Hasenöhrl, R. U., Häcker, R., Mattern, C., & Huston, J. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00241-x · Cited by 89
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture
Shimizu, K., Matsubara, K., Ohtaki, K., & Shiono, H. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00163-9 · Cited by 89
Tenuigenin treatment decreases secretion of the Alzheimer’s disease amyloid β-protein in cultured cells
Jia, H., Jiang, Y., Ruan, Y., Zhang, Y., Ma, X., Zhang, J., Beyreuther, K. T., Tu, P., & Zhang, D. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.093 · Cited by 88
857-860Anti-inflammatory Effect of Magnolol, Isolated from Magnolia officinalis , on A23187-induced Pleurisy in Mice
Wang, J.-P., Ho, T., Chang, L., & Chen, C. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05754.x · Cited by 85
Current Treatment and Recent Clinical Research in Alzheimer's Disease
Neugroschl, J. A., & Sano, M. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20165 · Cited by 84
Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: Effect of ginkgo biloba extract
Seif-El-Nasr, M., & ABDELFATTAH, A. (1995) · Pharmacological Research · doi:10.1016/s1043-6618(05)80014-3 · Cited by 82
Pharmacologic treatment of Alzheimer's disease: an update.
DeLaGarza, V. W. (2003) · PubMed · Cited by 82
Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats
Wang, L., Han, Y., & Tang, X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00291-0 · Cited by 81
Effects of Celastrus paniculatus on passive avoidance performance and biogenic amine turnover in albino rats
Nalini, K., Karanth, K. S., Rao, A., & Aroor, A. R. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01264-e · Cited by 81
Cerebral Protective and Cognition-Improving Effects of Sinapic Acid in Rodents
Karakida, F., Ikeya, Y., 綱川, 光., Yamaguchi, T., Ikarashi, Y., Takeda, S., & Aburada, M. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.514 · Cited by 78
Cholinesterase inhibition by galanthamine and lycoramine
Irwin, R. L., & Smith, H. J. (1960) · Biochemical Pharmacology · doi:10.1016/0006-2952(60)90030-7 · Cited by 78

Sorted by citations

Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Dutra, R. C., Campos, M. M., Santos, A. R. S., & Calixto, J. Β. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.021 · Cited by 485
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Makhoba, X. H., Viegas, C., Mosa, R. A., Viegas, F. P. D., & Pooe, O. J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s257494 · Cited by 337
Self-citation
Neuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 264
Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions
Dey, A., Bhattacharya, R., Mukherjee, A., & Pandey, D. K. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.005 · Cited by 232
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Marino, B. L. B., de Souza, L. R., Sousa, K. P. A., Ferreira, J. V., Padilha, E. C., da Silva, C. H. T. D. P., Taft, C. A., & Hage-Melim, L. I. D. S. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191104110908 · Cited by 239

See all 126

Authors: Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C.
Venue: CNS & Neurological Disorders - Drug Targets
Publisher: Bentham Science Publishers Ltd.
Published: 2011-03-01
Volume: 10
Issue: 2
Pages: 251-270
ISSN: 1568-007X (ISSN-L)
1871-5273
DOI: 10.2174/187152711794480429
OpenAlex: W2146833115
Cited by: 126
References: 294
Citations by year: 2026: 2 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 18 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 8 · 2012: 10
FWCI: 6.76
Type: journal article
Language: en
Open access: closed
Locations: CNS & Neurological Disorders - Drug Targets (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: Alzheimer's disease, natural products, phytochemicals, neuroprotection, amyloid plaques, amyloid-beta, tau protein, neurofibrillary tangles, neuroinflammation, secondary metabolites, drug discovery, ginseng, Salvia miltiorrhiza, turmeric, Ginkgo biloba, Huperzia serrata, Centella asiatica, Celastrus paniculatus, Magnolia officinalis, Polygala tenuifolia, Picrorhiza kurroa, cognitive impairment, mood and anxiety
MeSH terms: Alzheimer Disease, Biological Products, Central Nervous System, Humans, Neuroprotective Agents, Neurodegenerative Diseases, Drug Discovery, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks